Lantern Pharma and Actuate Therapeutics Announce Research & Development Collaboration Leveraging Lantern's Artificial Intelligence Platform
Go back to Lantern Pharma and Actuate Therapeutics Announce Research & Development Collaboration Leveraging Lantern's Artificial Intelligence Platform| (NASDAQ: LTRN) | Delayed: 1.55 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.55 | 52 Week High | $ | |||
| Open | $1.55 | 52 Week Low | $ | |||
| Day High | $1.55 | P/E | N/A | |||
| Day Low | $1.55 | EPS | $ | |||
| Volume | 1,948 | |||||

